Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Children's National Research Institute | OTHER |
Not provided
Not provided
Not provided
Not provided
The study is investigating if following the low glutamate diet for 1 month, as compared to care as usual, can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life in children with epilepsy.
Epilepsy is estimated to effect 470,000 children within the U.S. About a third of epilepsy patients are refractory. For these patients, dietary therapy is an alternative option. However, current dietary therapies present issues with compliance, palatability, adverse events, and providing necessary nutrients for brain growth and development during childhood. A dietary option that can improve tolerability, increase compliance, and reduce or eliminate adverse effects, while also optimizing nutrient intake, is critical for the advancement of dietary therapy options in epilepsy.
Glutamate is found in the diet as a flavor enhancer; and is also an important neurotransmitter in the body which mediates seizure activity. Dietary sources of free glutamate are common and include numerous food additives (including many hidden sources) and some items which naturally contain higher amounts of glutamate. The low glutamate diet reduces the consumption of free glutamate, while optimizing dietary micronutrient and antioxidant intake, which can protect against the negative effects caused by high glutamate concentrations in the brain. Additionally, the low glutamate diet is balanced, nutritious and palatable, with no side effects.
The study is investigating if following the low glutamate diet for 1 month can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life, in children with epilepsy. Participation in the study will be done virtually and over a 2- or 3- month study period, depending on group randomization. All participants will have the opportunity to undergo dietary training and follow the diet.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Wait-listed control | No Intervention | Participants continue care as usual. All all medications must be kept constant during the study period, unless medically necessary. | |
| Low Glutamate diet | Experimental | Participants are put on the low glutamate diet for one month. The low glutamate diet reduces the consumption of free glutamate, while optimizing dietary micronutrient and antioxidant intake. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Low Glutamate diet | Other | Participants will be given extensive online dietary training and assigned to follow the low glutamate diet for one month. The low glutamate diet reduces the consumption of free glutamate, while optimizing dietary micronutrient and antioxidant intake. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in seizure frequency | All families will keep a seizure diary recording the number of daily seizures. This will be used to accurately determine these variables for the last week, which will be recorded on seizure assessment forms. | At 1 month post treatment |
| Change in seizure severity | . During the last week of each study period, families will be asked to complete a seizure assessment form. This will include a subjective rating scale for seizure severity with a minimum score of 0 (not severe) and a maximum score of 10 (very severe). | At 1 month post treatment |
| Change in seizure duration | All families will keep a seizure diary recording the duration of seizures. This will be used to accurately determine these variables for the last week, which will be recorded on seizure assessment forms. | At 1 month post treatment |
| Measure | Description | Time Frame |
|---|---|---|
| The effect of a 1-month low-glutamate diet on quality of life in children with epilepsy. | Parents will be asked to complete the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55). This 55-question quality of life questionnaire has been validated for children ages 4 and older and is used to assess the participant's cognitive, emotional, social, and physical functioning. | At 1 month post treatment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kathleen Holton, MPH, PhD | American University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| American University | Washington D.C. | District of Columbia | 20016 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36867910 | Derived | Sarlo GL, Kao A, Holton KF. Investigation of the low glutamate diet as an adjunct treatment for pediatric epilepsy: A pilot randomized controlled trial. Seizure. 2023 Mar;106:138-147. doi: 10.1016/j.seizure.2023.02.013. Epub 2023 Feb 20. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000069279 | Drug Resistant Epilepsy |
| ID | Term |
|---|---|
| D004827 | Epilepsy |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Randomized controlled trial
Not provided
Not provided
Not provided
Not provided
| The effect of a 1-month low-glutamate diet on cognitive functioning in children with epilepsy. | Cognitive function will be assessed via CNSVS, a computerized neurocognitive testing software. | At 1 month post treatment |
| Examine change in resting state brain waves after 1-month on the low glutamate diet | Electroencephalography (EEG) will be offered to all participants. Four minutes of eyes-closed and eyes-open resting state EEG data will be recorded at the end of the baseline, wait-listed control, and active intervention periods in a sound-attenuated, air-conditioned room. Participants will sit in a comfortable chair in front of a computer monitor. For eyes-closed recordings, participants will be instructed to sit as still as possible, while staying relaxed but awake. For eyes-open recordings, participants will be instructed to sit as still as possible and to focus on a fixation point on the screen while keeping blinking to a minimum, if possible. Participants will be monitored to make sure they are complying with condition instructions. Mean power (total power of frequency band/width of frequency band) and relative power (absolute power of frequency band/total power or percent) will be calculated for delta, theta, alpha, beta, gamma, high gamma, and total power. | At 1 month post treatment |